Recent guidelines suggest that both low- and high-risk patients can safely stop antibiotics when afebrile, clinically well and have completed an adequate treatment course, irrespective of neutrophil count in febrile neutropenia. This marks a departure from the usual practice of awaiting marrow recovery.
